Compounds > enbucrilate
Page last updated: 2024-08-22

enbucrilate and Hepatic Encephalopathy

enbucrilate has been researched along with Hepatic Encephalopathy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Kimura, K; Osaki, A; Sato, M; Takaku, K; Terai, S; Waguri, N; Watanabe, Y; Yamazaki, H; Yamazaki, S1
Korsic, S; Popovic, P; Skok, P; Stabuc, B1

Other Studies

2 other study(ies) available for enbucrilate and Hepatic Encephalopathy

ArticleYear
Two cases of portal-systemic encephalopathy caused by multiple portosystemic shunts successfully treated with percutaneous transhepatic obliteration.
    Clinical journal of gastroenterology, 2022, Volume: 15, Issue:5

    Topics: Aged; Enbucrilate; Female; Hepatic Encephalopathy; Humans; Iopamidol; Male; Middle Aged; Portal Vein; Portasystemic Shunt, Transjugular Intrahepatic

2022
TIPS
    Radiology and oncology, 2021, 01-26, Volume: 55, Issue:2

    Topics: Cause of Death; Enbucrilate; Endoscopy; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hypertension, Portal; Liver Failure; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Recurrence; Retrospective Studies; Sclerosing Solutions; Secondary Prevention; Stents

2021